Nalaganje...
CDK4/6 inhibition in luminal breast cancer
Endocrine therapy represents the basis for the treatment of estrogen receptor-positive breast cancer, but several tumors harbor intrinsic resistance and acquired resistance to endocrine therapy is inevitable in metastatic disease. Combination strategies of endocrine therapy with targeted agents are...
Shranjeno v:
| izdano v: | Memo |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Vienna
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923084/ https://ncbi.nlm.nih.gov/pubmed/27429659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0268-2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|